STOCK TITAN

CYANOTECH CORP - $CYAN STOCK NEWS

Welcome to our dedicated page for CYANOTECH news (Ticker: $CYAN), a resource for investors and traders seeking the latest updates and insights on CYANOTECH stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CYANOTECH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CYANOTECH's position in the market.

Rhea-AI Summary
Nutrex-Hawaii, Inc., a subsidiary of Cyanotech , introduces a new sugar-free gummy format for its BioAstin® Hawaiian Astaxanthin® dietary supplement, offering 12mg of natural Hawaiian Astaxanthin per serving. The gummies are sourced from natural Hawaiian microalgae grown outdoors, backed by scientific research, and ensure origin traceability and sustainability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
none
-
Rhea-AI Summary
Cyanotech Corporation (Nasdaq Capital Market: CYAN) reported a decrease in net sales for the third quarter and first nine months of fiscal year 2024, with lower sales across the portfolio due to macroeconomic challenges and consumer trading down to private label brands. The company's operating loss and net loss increased compared to the same period in the prior year, reflecting a challenging market for bulk material and price sensitivity. Despite these challenges, Cyanotech is focusing on revitalizing its sales and marketing team and enhancing customer messaging to highlight its premium quality and competitive advantages.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.94%
Tags
-
Rhea-AI Summary
Cyanotech Corporation (Nasdaq Capital Market: CYAN) announced a 23.1% increase in net sales for the second quarter fiscal year 2024, with a gross profit margin of 32.8%. However, the first six months of fiscal 2024 saw a 3.2% decrease in net sales. The company's President and CEO emphasized the focus on driving demand in the naturally derived algae space and managing spend in line with customer demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.24%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.37%
Tags
-
Rhea-AI Summary
CYAN: Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer, Expanding Leadership Team and Enhancing Product Portfolio
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.69%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.9%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.15%
Tags
CYANOTECH CORP

OTC:CYAN

CYAN Rankings

CYAN Stock Data

2.27M
5.00M
32.79%
4.84%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Kailua-Kona

About CYAN

cyanotech corporation is an accounting company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.